Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II

Gastroenterology

Volumn 125, Issue 1, 2003, Pages 117-125

  Bataller, Ramón ^a,b   Sancho Bru, Pau ^a,b   Ginès, Pere ^a,b,d   Lora, José M ^c   Al Garawi, Amal ^c   Solé, Manel ^a   Colmenero, Jordi ^a,b   Nicolás, Josep M ^a   Jiménez, Wladimiro ^a   Weich, Nadine ^c   Gutiérrez Ramos, José Carlos ^c   Arroyo, Vicente ^a,b   Rodés, Juan ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Inst Reina Sofia Invest Nefrol ^*  (Spain)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; RENIN; THROMBIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CULTURE; LIVER CIRRHOSIS; LIVER REGENERATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 0037772442     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00695-4     Document Type: Article

References (37)

1. Laragh JH, Sealey JE. Renin-angiotensin-aldosterone system and the renal regulation of sodium, potassium, and blood pressure homeostasis, In: Windhager EE, ed. Renal physiology. Oxford: Oxford University Press, 1992:1409-1542.
2. Gunther S, Alexander RW, Atkinson WJ, Gimbrone MA Jr. Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol 1982;92:289-298.
3. Lumbers ER. Angiotensin and aldosterone. Regul Pept 1999;80: 91-100.
4. DeMello WC, Danser J. Angiotensin II and the heart. On the intracrine renin-angiotensin system. Hypertension 2000;35: 1183-1188.
5. Harris RC, Cheng HF. The intrarenal renin-angiotensin system: a paracrine system for the local control of renal function separate from the systemic axis. Exp Nephrol 1996;4(Suppl 1):2-7.
6. Anderson S. Role of local and systemic angiotensin in diabetic renal disease. Kidney Int Suppl 1997;63:S107-S110.
7. Weber KT, Sun Y, Katwa LC. Myofibroblasts and local angiotensin II in rat cardiac tissue repair. Int J Biochem Cell Biol 1997;29: 31-42.
8. Katwa LC, Campbell SE, Tyagi SC, Lee SJ, Cicila GT, Weber KT. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 1997;29:1375-1386.
9. Matsusaka T, Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol 1997;59:395-412.
10. Weber KT, Sun Y, Katwa LC, Cleutjens JP. Tissue repair and angiotensin II generated at sites of healing. Basic Res Cardiol 1997;92:75-78.
11. Takenaka T, Suzuki H, Fujiwara K, Kanno Y, Ohno Y, Hayashi K, Nagahama T, Saruta T. Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II. J Clin Invest 1997; 100:2107-2114.
12. Chansel D, Czekalski S, Pham P, Ardaillou R. Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am J Physiol 1992;262:F432-F441.
13. Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension 2001;38:635-638.
14. Re RN. The clinical implication of tissue renin angiotensin systems. Curr Opin Cardiol 2001;16:317-327.
15. Unger T. The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 2002;89:3A-9A.
16. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001;34:745-750.
17. Ohishi T, Saito H, Tsusaka K, Toda K, Inagaki H, Hamada Y, Kumagai N, Atsukawa K, Ishii H. Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetra-chloride-induced hepatic fibrosis in rats. Hepatol Res 2001;21: 147-158.
18. Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, Purdie DM, Powell EE. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001;121:148-155.
19. Paizis G, Gilbert RE, Cooper ME, Murthi P, Schembri JM, Wu LL, Rumble JR, Kelly DJ, Tikellis C, Cox A, Smallwood RA, Angus PW. Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 2001;35:376-385.
20. Bataller R, Ginès P, Nicolàs JM, Görbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rodés J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000;118:1149-1156.
21. Bataller R, Schwabe RF, Qian T, Lemasters JJ, Brenner DA. Angiotensin II stimulates the secretion of proinflammatory cytokines in human hepatic stellate cells via MAPk activation induced by oxidative stress (abstr.) Hepatology 2001;34:400A.
22. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000;275: 2247-2250.
23. Bataller R, Brenner DA. Activated hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 2001; 21:437-451.
24. Reynaert H, Thompson MG, Thomas T, Geerts A. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 2002;50:571-581.
25. Bataller R, Nicolás JM, Ginès P, Esteve A, Görbig MN, García-Ramallo E, Pinzani M, Jiménez W, Ros J, Jiménez W, Thomas A, Arroyo V, Rodés J. Arginine vasopressin induces contraction and stimulates growth in cultured human hepatic stellate cells. Gastroenterology 1997;113:615-624.
26. Bataller R, Gasull X, Ginès P, Hellemans K, Görbig MN, Nicolás JM, Sancho-Bru P, De las Heras D, Gual A, Geerts A, Arroyo V, Rodés J. In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology 2001;33:956-962.
27. De Gasparo M, Siragy HM. The AT2 receptor: fact, fancy and fantasy. Regul Pept 1999;81:11-24.
28. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 2001;81:999-1030.
29. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Tosti-Guerra C, Maggi M, Failli P, Ruocco C, Gentilini P. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996;110:534-548.
30. Marra F, Grandaliano G, Valente AJ, Abboud HE. Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: potential role in liver injury. Hepatology 1995;22:780-787.
31. Rockey DC, Fouassier L, Chung JJ, Carayon A, Vallee P, Rey C, Housset C. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology 1998;27:472-480.
32. Rossi GP, Seccia TM, Nussdorfer GG. Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. Int Rev Cytol 2001;209: 241-272.
33. Sugo S, Minamino N, Shoji H, Isumi Y, Nakao K, Kangawa K, Matsuo H. Regulation of endothelin-1 production in cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol 2001;37: 25-40.
34. Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-López F, Rodés J. Effect of angiotensin-II blockade on systemic and hepatic hemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites. Eur J Clin Invest 1981;11:221-229.
35. Rockey DC. Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy. Gastroenterology 2000;118:1261-1265.
36. Schneider AW, Kalk JF, Klein CP. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 1999;29:334-339.
37. González-Abraldes J, Albillos A, Bañares R, Del Arbol LR, Moitinho E, Rodriguez C, González M, Escorsell A, Garcia-Pagan JC, Bosch J. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology 2001;121:382-388.